HomeIDEAFORGE › Filing
🔔 Get instant alerts when IDEAFORGE files quarterly results on BSE Start free trial →

Press Release

Filed: 10 Aug 2026, 20:23 IST Exchange: NSE Category: Financial Results — Press Release
Press Release - Q1FY27 - Revenue ₹68.6 Cr +436% y-y; EBITDA ₹4.3 Cr (margin 6.2% vs -118.5%); PAT -₹2.6 Cr - Executed over 20% of FY27 opening order book; targets full delivery by Q3 FY27 - Completed ₹500 Cr QIP with strong domestic and global institutional participation - Progress on combat drone tech: air-launched effects and fuel-hybrid long-endurance for ZOLT - Secured DGCA Type Certification for Q6 V2 GEO UAV, expanding GIS and mapping market - Received ₹151 Cr RDI funding for YETI middle-mile logistics UAV development - CEO: "Higher operational procurement limits under DFPDS 2026 to accelerate Q3/Q4 orders"
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 IDEAFORGE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add IDEAFORGE to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Ideaforge Technology Limited

Important. The summary above is generated automatically from Ideaforge Technology Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.